Lobesity Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $113M

Lobesity General Information

Description

Developer of pharmaceutical products designed to prevent obesity. The company engages in the development and discovery of therapies for non-alcoholic fatty liver disease, hepatic steatosis, and obesity, thereby providing medical practitioners with a pharmaceutical agent to prevent obesity.

Contact Information

Formerly Known As
eXcilis
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11000 Cedar Avenue
  • Cleveland, OH 44106-3052
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 11000 Cedar Avenue
  • Cleveland, OH 44106-3052
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lobesity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Jul-2021 $113M Completed Generating Revenue
1. Early Stage VC 30-Apr-2016 Completed Pre-Clinical Trials
To view Lobesity’s complete valuation and funding history, request access »

Lobesity Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioEnterprise Not-For-Profit Venture Capital Minority
To view Lobesity’s complete investors history, request access »

Lobesity FAQs

  • When was Lobesity founded?

    Lobesity was founded in 2015.

  • Where is Lobesity headquartered?

    Lobesity is headquartered in Cleveland, OH.

  • What industry is Lobesity in?

    Lobesity’s primary industry is Drug Discovery.

  • Is Lobesity a private or public company?

    Lobesity is a Private company.

  • What is the current valuation of Lobesity?

    The current valuation of Lobesity is .

  • What is Lobesity’s current revenue?

    The current revenue for Lobesity is .

  • How much funding has Lobesity raised over time?

    Lobesity has raised $722K.

  • Who are Lobesity’s investors?

    BioEnterprise has invested in Lobesity.

  • When was Lobesity acquired?

    Lobesity was acquired on 19-Jul-2021.

  • Who acquired Lobesity?

    Lobesity was acquired by 9 Meters Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process